Receptors LLC Company Information

Owner and Chief Executive of Vomela Specialty Company in St. Paul, MN 1990- Present
Vomela has seen revenues increase from $3 million in 1990 to over $40 million in 2004.
Mr. Auth has been involved as either an investor or a corporate CEO in the acquisition of more than 20 companies. Most notably, Mr.Auth was Chairman and CEO of ITI Technologies, Inc., a global security, life safety, systems software and communications company. Under his leadership ITI experienced tremendous growth and success. The company was recognized three times by Business Week and Forbes magazines as being among the best small companies in America. Mr. Auth was recognized in 1985 as the St. Paul, Minnesota Small Businessman of the Year. In the 20 years that Mr.Auth was CEO of ITI he raised over $120 million in financing and built annual sales to $125 million. In 2000, ITI merged with INTERLOGIX, Inc. which was then sold to General Electric in 2002.
www.vomela.com

Dr. Robert E. Carlson

Founding President of ECOCHEM Research, Inc. Founded 1985; Chaska MN. Research and Development at the Chemistry / Biology Interface.
Founding Senior Partner of CAPE Technology LLC. Founded 1996; South Portland, ME. High Performance Immunotechnology Products for Environmental Analysis (www.cape-tech.com).
Founding Chairman and President of RECEPTORS LLC
Dr. Carlson is the inventor of the Combinatorial Artificial Receptor Array (CARA®) technology and serves as RECEPTORS' President and Principal Investigator.
Dr. Carlson has direct experience in the development and commercialization of immunotechnology and pharmaceutical products with over 30 publications and 3 patents in areas relevant to RECEPTORS' goals.
Dr. Carlson has applied for over 20 patents on behalf of RECEPTORS LLC.
www.receptorsllc.com

Dr. Robert M. Carlson

Professor, Department of Chemistry, University of Minnesota, Duluth. 1966 - current; Duluth, MN.
Cofounder, Apprise Technologies, Duluth, Mn; Optical sensor products for environmental analysis.
Robert M. Carlson has authored over 70 publications and has been listed as an inventor on about 15 patents and patents pending. His research has focused on the development of new methods for the synthesis of biologically-active natural products, environmental analytical chemistry and the development of value-added products derived from the waste streams of forest product industries.
Dr. Carlson serves as the chairman of the RECEPTORS' Science Advisory Board.
Dr. Carlson has experience in both research and development management and the development of technology based products and companies.
www.d.umn.edu/chem/

Randolph K. Geissler

Randolph Geissler currently is the Principal of Brookwood Technology Holdings Company. His purpose is to selectively invest in technologies and companies and then be instrumental in the strategic development of those technologies and companies.
Mr. Geissler has over 15 years of experience as CEO and served as Chief Executive Officer and President of Digital Angel Corporation (Amex: DOC) from March 2000 until September 2003.
Prior to joining Digital Angel Corporation in 2000, Geissler served as Chief Executive Officer of Destron Fearing Corporation (NASDAQ: DFCO), a company that he founded in 1993 via the merger of his private company, Fearing Manufacturing, with Destron. This merger propelled the implantable electronic microchip into a worldwide success in the animal empire. Geissler also was President and Chief Executive Officer of Fearing.
He has held Directorships on several public and private company boards.
Prior to 1987, he held a variety of positions with Fearing Manufacturing Co., Inc., including product manager and director of corporate research and development-ectoparaciticides.

Dr. Andrew D. Hamilton

Deputy Provost for Science & Technology, Irenee DuPont Professor of Chemistry, Professor Molecular Biophysics & Biochemisty, Yale University.
Dr. Hamilton has over 250 publications and 20 patents and patents pending. His research is focused on molecular recognition and the application of artificial receptors to pharmaceutical development.
Dr. Hamilton is a world leader in the development and application of artificial receptors.
http://ursula.chem.yale.edu/~hamgrp/

Mr. Richard A. Hoel

Founding shareholder of Winthrop & Weinstine, P.A., a Minneapolis law firm. Founded in 1979
Director and investor in Duke Financial Group, Inc.; Automated Management Technologies, Inc.; Automotive Cooling Products, Inc.; Pyramid Manufacturing, Inc.; Aero Systems Engineering, Inc.; and Minnesota ASE, LLC.
General corporate law with an emphasis on mergers and acquisitions.
Active investor in start-up and mature companies.
www.winthrop.com

Dr. Thomas J. Kodadek

Professor, Departments of Medicine and Molecular Biology, University of Texas Southwestern Medical Center.
Co-Director of the Center for Biomedical Inventions at UT-Southwestern
Fellow of the AAAS
Dr. Kodadek is the author or co-author of over 100 research articles and two patents in many areas of chemistry and biology.
Dr. Kodadek's current research interests include the regulation of gene transcription and the development of new technologies for proteomics research.
http://kodadeklab.swmed.edu

Mr. Douglas M. Kratz

Chairman, National Bancshares, Inc., Bettendorf, Iowa, a community banking organization with offices in both Iowa and Illinois.
Chairman, One Corporation, Naples, Florida, an investment firm with debt/equity holdings in various privately owned entities.
Director and a principal investor in JMF Company, a wholesale distribution company based in Bettendorf, Iowa.
Active investor in public debt/equity markets.
www.jmfcompany.com

Mr. Chetan N. Patel

Current owner, Corporate President and co-founder (in 1986) of Scientific Moldings Corporation, Ltd. (SMC)
24 years of experience in plastic research and engineering in the US and abroad.
Positions held by Mr. Patel include: Service Engineer, Design Engineer, Project Engineer and Manager of Engineering. These positions were with four highly respected companies in the plastics manufacturing industry.
Graduated from the University Of Bombay, India, majoring in Plastics Engineering. Earned a M.S. in Plastics Engineering from the University of Lowell, Lowell, MA.

Dr. Lawrence Que, Jr.

Professor, Department of Chemistry, University of Minnesota, Minneapolis, MN. 1987-present.
Director, Center for Metals in Biocatalysis, University of Minnesota, Minneapolis, MN. 1994-present.
Dr. Que has over 280 publications and 4 patents. His research is focused on the role of metals in Biocatalysis and the application of metallo complexes to chemical transformation.
Dr. Que is a recognized leader in the development of artificial enzymes.
http://bioinorg.chem.umn.edu/quespace/

Dr. Mark T. Skoog

Partner, Merchant & Gould. 2003-Present; Minneapolis Minnesota.
Associate Attorney, Merchant & Gould. 1996-2002; Minneapolis Minnesota.
A Ph.D. in Biochemistry, Dr. Skoog practices Intellectual Property law with an emphasis on patent prosecution and client counseling. Before becoming a patent attorney, Dr. Skoog spent a decade as a researcher and research manager in the pharmaceutical industry searching for therapies for inflammatory, autoimmune, and viral diseases. Dr. Skoog's practice areas include obtaining patent protection and evaluating patents in fields including biotechnology, chemistry, and pharmaceuticals. www.merchant-gould.com

952-448-4337